K Number
K101778
Device Name
GIRAFFE INCUBATOR
Manufacturer
Date Cleared
2010-07-21

(26 days)

Product Code
Regulation Number
880.5400
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The Giraffe Incubator is an Infant Incubator. Incubators provide heat in a controlled manner to neonates who are unable to thermo-regulate based on their own physiology. They achieve this by providing an enclosed temperature controlled environment to the infant. This device may incorporate a Servo Controlled Oxygen Delivery System. This is indicated to provide a stable oxygen concentration within the infant compartment at the value set by the operator (21-65%).
Device Description
The Giraffe Incubator is an infant bed, which provides thermal support for infants who are unable to provide for their own heat requirements. The device maintains the infant's temperature by circulating heated air within the enclosed bed compartment. The operator may select either the air or skin temperature control method. Depending on the control method selected, heat is regulated based on either the air temperature or the infant's skin temperature compared to the operator selected control temperature. Physical access to the patient is obtained through the side portholes or by opening one of the side doors. The optional Giraffe Servo Control Oxygen Delivery System is a fully integrated option available on the Giraffe Incubator. The Giraffe Servo Control Oxygen Delivery System is capable of oxygenating the entire infant compartment at oxygen concentrations of 21%-65% by volume. The device uses fuel cell type sensors that generate specific voltages depending on the oxygen concentrations they contact. The microprocessor stores the sensor output and compares it with the value corresponding to the concentration set by the operator. The valves that supply oxygen to the infant compartment are opened and closed as necessary to maintain the oxygen concentration at the set value. Fluctuations in fuel cell performance due to temperature and humidity are compensated for by the microprocessor. The Giraffe and Panda Uninterruptible Power Supply (UPS) provides a short term source of electrical power to the Giraffe Incubator, thus aiding its intra hospital mobility. The Giraffe UPS does not change the indications for use, control mechanisms, operating principles, performance specifications, or other features of the Giraffe Incubator. The UPS serves as an extension to the Giraffe Incubator by providing uninterrupted electric power to the device. The UPS comprises a medical grade battery and a shelf. When used with the UPS, the Giraffe Incubator is not intended for use as transport incubator or to be taken outside of the hospital building. The proposed modification of the Giraffe Incubator is the addition of the Giraffe Shuttle accessory. The Giraffe Incubator can be used with the Giraffe Shuttle, a mobile power source that allows for transport of the patient between care areas within the hospital building and provides power to the Incubator. These areas include, but are not limited to Labor and Delivery, NICU, Radiology, and Operating Room. This eliminates the need to transfer the infant to and from a transport incubator for transport within the hospital building, reducing the potential for clinical problems associated with patient touch, handling and movement. This reduces the potential for clinical problems associated with intra-hospital transport that result from interrupted patient thermal regulation. . Similarly to the UPS accessory, the Shuttle facilitates the mobility of the Giraffe Incubator within the hospital building. Giraffe Incubator when used with the UPS or with the Shuttle is not a transport incubator and is not intended to be used outside of the hospital building. The Shuttle has two primary active functions: Locking to a bed and providing transportable power to the bed and accessories. Attaching the Shuttle to a bed is accomplished by guiding the Shuttle between the legs of the bed and stepping on the Lock pedal. This effectively locks the Shuttle and bed together as one unit. To detach the Shuttle from the bed, the locking arms are rotated back to their unlocked position by stepping on the Unlock pedal. Once unlocked, the Shuttle can be moved away from the bed. The internal power source of the Shuttle consists of two 12 volt 42 amp hour lead acid batteries. The batteries are high capacity, sealed, no-maintenance batteries and are connected in series to provide a nominal 24 volts supply to the power generation module. The Shuttle contains two sensor systems: - One system detects an interference condition. - The other system determines the attaching status of the device. The Shuttle features an LED Display Board, which contains the battery runtime indicator and the battery health indicator.
More Information

Not Found

No
The device description focuses on basic control systems (thermoregulation, oxygen delivery) using sensors and a microprocessor for comparison and compensation. There is no mention of learning, adaptation, or complex pattern recognition characteristic of AI/ML. The added accessories (UPS, Shuttle) are power and mobility solutions with simple sensor systems.

Yes
The device is a therapeutic device because it provides heat to neonates who are unable to thermoregulate, and may also provide stable oxygen concentration, which directly treats a physiological need.

No

The device is an infant incubator designed to provide thermal support and oxygen delivery to neonates. While it uses sensors to maintain desired oxygen levels and temperature, its primary function is therapeutic (providing a controlled environment), not diagnostic (identifying or characterizing a disease or condition).

No

The device description clearly details physical components such as an infant bed, heating elements, oxygen delivery system with sensors and valves, a power supply with batteries, and a mobile shuttle with locking mechanisms and an LED display. While it mentions a microprocessor for control, the core functionality and components are hardware-based.

Based on the provided text, the Giraffe Incubator is not an In Vitro Diagnostic (IVD) device.

Here's why:

  • Intended Use: The intended use is to provide thermal support and controlled oxygen delivery to neonates. This is a direct intervention on the patient's physiology, not an analysis of samples taken from the patient.
  • Device Description: The device description details how the incubator provides a controlled environment and how the oxygen delivery system works. It focuses on physical parameters and direct patient support.
  • Lack of IVD Characteristics: The text does not mention any analysis of biological samples (blood, urine, tissue, etc.), diagnostic testing, or the use of reagents.

IVD devices are specifically designed to examine specimens derived from the human body to provide information for the diagnosis, prevention, or treatment of a disease or condition. The Giraffe Incubator does not perform this function.

N/A

Intended Use / Indications for Use

The Giraffe Incubator is an Infant Incubator. Incubators provide heat in a controlled manner to neonates who are unable to thermo-regulate based on their own physiology. They achieve this by providing an enclosed temperature controlled environment to the infant. This device may incorporate a Servo Controlled Oxygen Delivery System. This is indicated to provide a stable oxygen concentration within the infant compartment at the value set by the operator (21-65%).

Product codes

FMZ

Device Description

The Giraffe Incubator is an infant bed, which provides thermal support for infants who are unable to provide for their own heat requirements. The device maintains the infant's temperature by circulating heated air within the enclosed bed compartment. The operator may select either the air or skin temperature control method. Depending on the control method selected, heat is regulated based on either the air temperature or the infant's skin temperature compared to the operator selected control temperature. Physical access to the patient is obtained through the side portholes or by opening one of the side doors. The optional Giraffe Servo Control Oxygen Delivery System is a fully integrated option available on the Giraffe Incubator. The Giraffe Servo Control Oxygen Delivery System is capable of oxygenating the entire infant compartment at oxygen concentrations of 21%-65% by volume. The device uses fuel cell type sensors that generate specific voltages depending on the oxygen concentrations they contact. The microprocessor stores the sensor output and compares it with the value corresponding to the concentration set by the operator. The valves that supply oxygen to the infant compartment are opened and closed as necessary to maintain the oxygen concentration at the set value. Fluctuations in fuel cell performance due to temperature and humidity are compensated for by the microprocessor.

The Giraffe and Panda Uninterruptible Power Supply (UPS) provides a short term source of electrical power to the Giraffe Incubator, thus aiding its intra hospital mobility. The Giraffe UPS does not change the indications for use, control mechanisms, operating principles, performance specifications, or other features of the Giraffe Incubator. The UPS serves as an extension to the Giraffe Incubator by providing uninterrupted electric power to the device. The UPS comprises a medical grade battery and a shelf.

When used with the UPS, the Giraffe Incubator is not intended for use as transport incubator or to be taken outside of the hospital building.

The proposed modification of the Giraffe Incubator is the addition of the Giraffe Shuttle accessory.

The Giraffe Incubator can be used with the Giraffe Shuttle, a mobile power source that allows for transport of the patient between care areas within the hospital building and provides power to the Incubator. These areas include, but are not limited to Labor and Delivery, NICU, Radiology, and Operating Room.

This eliminates the need to transfer the infant to and from a transport incubator for transport within the hospital building, reducing the potential for clinical problems associated with patient touch, handling and movement. This reduces the potential for clinical problems associated with intra-hospital transport that result from interrupted patient thermal regulation. .

Similarly to the UPS accessory, the Shuttle facilitates the mobility of the Giraffe Incubator within the hospital building. Giraffe Incubator when used with the UPS or with the Shuttle is not a transport incubator and is not intended to be used outside of the hospital building.

The Shuttle has two primary active functions: Locking to a bed and providing transportable power to the bed and accessories.

Attaching the Shuttle to a bed is accomplished by guiding the Shuttle between the legs of the bed and stepping on the Lock pedal. This effectively locks the Shuttle and bed together as one unit.

To detach the Shuttle from the bed, the locking arms are rotated back to their unlocked position by stepping on the Unlock pedal. Once unlocked, the Shuttle can be moved away from the bed.

The internal power source of the Shuttle consists of two 12 volt 42 amp hour lead acid batteries. The batteries are high capacity, sealed, no-maintenance batteries and are connected in series to provide a nominal 24 volts supply to the power generation module.

The Giraffe Shuttle is a transportable power source that is an accessory to the Giraffe Incubator. The Shuttle connects to the bed and provides electrical power to the bed and other auxiliary equipment, required for patient care during transport.

The Shuttle is configured to attach to the Giraffe Incubator and provide electrical power to the bed and selected accessories. The Shuttle makes it possible to deliver continuous baby care during transport from one hospital area to another (e.g. from L&D to NICU).

The Shuttle is designed to accept all Shuttle-specific accessories from GE Healthcare, including: the cord wrap bracket and gas cylinder holder.

The Shuttle has two primary active functions: Locking to a bed and providing transportable power to the bed and accessories.

The Shuttle contains two sensor systems:

  • One system detects an interference condition.
  • The other system determines the attaching status of the device.

The Shuttle features an LED Display Board, which contains the battery runtime indicator and the battery health indicator.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

neonates

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Non-Clinical Tests: Determination of Substantial Equivalence:
The Giraffe Incubator and its applications with the Giraffe Shuttle, complies with voluntary standards as detailed in Section 9, 11 and 17 of this premarket submission. The following quality assurance measures were applied to the development of the system:

  • Risk Analysis .
  • Requirements Reviews
  • . Design Reviews
  • Testing on unit level (Module verification)
  • . Integration testing (System verification)
  • . Performance testing (Verification)
  • . Safety testing (Verification)
  • . Usability testing (Validation)
  • . Biocompatibility testing

Clinical Tests:
The subject of this premarket submission, Giraffe Incubator used with Shuttle, did not require clinical studies to support substantial equivalence.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

Giraffe Incubator

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 880.5400 Neonatal incubator.

(a)
Identification. A neonatal incubator is a device consisting of a rigid boxlike enclosure in which an infant may be kept in a controlled environment for medical care. The device may include an AC-powered heater, a fan to circulate the warmed air, a container for water to add humidity, a control valve through which oxygen may be added, and access ports for nursing care.(b)
Classification. Class II (performance standards).

0

K10178
1 of 4

Image /page/0/Picture/1 description: The image shows the General Electric (GE) logo. The logo consists of the letters "GE" in a stylized, cursive font, enclosed within a circular border. There are small, decorative swirls or flourishes at the top and bottom of the circle, adding a touch of elegance to the design. The logo is black and white.

i

JUL 21 2010

GE Healthcare Special 510(k) Premarket Notification Submission 510(k) Summary

In accordance with 21 CFR 807.92 the following summary of information is provided:

Date:June 17 2010
Submitter:Ohmeda Medical, a Division of Datex-Ohmeda, Inc., A General Electric
Company
8880 Gorman Rd.
Laurel, MD 20723
Primary Contact Person:Agata Smieja
8880 Gorman Rd.
Laurel, MD 20723
Tel: 410-456-0329
Fax: 410 888 0544
Secondary Contact Person:Andrew Ahn
8880 Gorman Rd.
Laurel, MD 20723
Tel: 410-888-5332
Fax: 410 888 0544
Device: Trade Name:Giraffe Incubator
Common/Usual Name:Incubator
Classification Names:Incubator, Neonatal: FMZ (880.5400)
Product Code:
Predicate Device(s):Giraffe Incubator
Legally Marketed Device
Device and Change Description:The Giraffe Incubator is an infant bed, which provides thermal support
for infants who are unable to provide for their own heat requirements.
The device maintains the infant's temperature by circulating heated air

within the enclosed bed compartment. The operator may select either the air or skin temperature control method. Depending on the control method selected, heat is regulated based on either the air temperature or the infant's skin temperature compared to the operator selected control temperature. Physical access to the patient is obtained through the side portholes or by opening one of the side doors. The optional Giraffe Servo Control Oxygen Delivery System is a fully integrated option available on the Giraffe Incubator. The Giraffe Servo Control Oxygen Delivery System is capable of oxygenating the entire infant compartment at oxygen concentrations of 21%-65% by volume. The device uses fuel cell type sensors that generate specific voltages depending on the oxygen concentrations they contact. The microprocessor stores the sensor output and compares it with the

1

Image /page/1/Picture/0 description: The image shows the General Electric (GE) logo. The logo consists of the letters 'GE' intertwined within a circular border. The letters and the border are black, creating a strong contrast.

K 10/778
2 of 4

GE Healthcare

Special 510(k) Premarket Notification Submission

value corresponding to the concentration set by the operator. The valves that supply oxygen to the infant compartment are opened and closed as necessary to maintain the oxygen concentration at the set value. Fluctuations in fuel cell performance due to temperature and humidity are compensated for by the microprocessor.

The Giraffe and Panda Uninterruptible Power Supply (UPS) provides a short term source of electrical power to the Giraffe Incubator, thus aiding its intra hospital mobility. The Giraffe UPS does not change the indications for use, control mechanisms, operating principles, performance specifications, or other features of the Giraffe Incubator. The UPS serves as an extension to the Giraffe Incubator by providing uninterrupted electric power to the device. The UPS comprises a medical grade battery and a shelf.

When used with the UPS, the Giraffe Incubator is not intended for use as transport incubator or to be taken outside of the hospital building.

Description of Device Modification

The proposed modification of the Giraffe Incubator is the addition of the Giraffe Shuttle accessory.

The Giraffe Incubator can be used with the Giraffe Shuttle, a mobile power source that allows for transport of the patient between care areas within the hospital building and provides power to the Incubator. These areas include, but are not limited to Labor and Delivery, NICU, Radiology, and Operating Room.

This eliminates the need to transfer the infant to and from a transport incubator for transport within the hospital building, reducing the potential for clinical problems associated with patient touch, handling and movement. This reduces the potential for clinical problems associated with intra-hospital transport that result from interrupted patient thermal regulation. .

Similarly to the UPS accessory, the Shuttle facilitates the mobility of the Giraffe Incubator within the hospital building. Giraffe Incubator when used with the UPS or with the Shuttle is not a transport incubator and is not intended to be used outside of the hospital building.

The Shuttle has two primary active functions: Locking to a bed and

2

Image /page/2/Picture/0 description: The image shows the General Electric (GE) logo. The logo consists of the letters "GE" intertwined and enclosed within a circle. There are three small, stylized teardrop shapes spaced evenly around the outer edge of the circle.

r

K10/778
3 of 4

GE Healthcare

Special 510(k) Premarket Notification Submission providing transportable power to the bed and accessories.

Attaching the Shuttle to a bed is accomplished by guiding the Shuttle between the legs of the bed and stepping on the Lock pedal. This effectively locks the Shuttle and bed together as one unit.

To detach the Shuttle from the bed, the locking arms are rotated back to their unlocked position by stepping on the Unlock pedal. Once unlocked, the Shuttle can be moved away from the bed.

The internal power source of the Shuttle consists of two 12 volt 42 amp hour lead acid batteries. The batteries are high capacity, sealed, no-maintenance batteries and are connected in series to provide a nominal 24 volts supply to the power generation module.

Legally Marketed Device Intended Use:

The intended use of the legally marketed device and the proposed modified device is identical. The intended use is as follows:

The Giraffe Incubator is an Infant Incubator. Incubators provide heat in a controlled manner to neonates who are unable to thermo-regulate based on their own physiology. They achieve this by providing an enclosed temperature controlled environment to the infant. This device may incorporate a Servo Controlled Oxygen Delivery System. This is indicated to provide a stable oxygen concentration within the infant compartment at the value set by the operator (21-65%).

The Giraffe Shuttle is a transportable power source that is an Device Modification accessory to the Giraffe Incubator. The Shuttle connects to the bed Technology: and provides electrical power to the bed and other auxiliary equipment, required for patient care during transport.

The Shuttle is configured to attach to the Giraffe Incubator and provide electrical power to the bed and selected accessories. The Shuttle makes it possible to deliver continuous baby care during transport from one hospital area to another (e.g. from L&D to NICU).

The Shuttle is designed to accept all Shuttle-specific accessories from GE Healthcare, including: the cord wrap bracket and gas cylinder holder.

The Shuttle has two primary active functions: Locking to a bed and providing transportable power to the bed and accessories.

The Shuttle contains two sensor systems:

3

Image /page/3/Picture/0 description: The image shows the General Electric (GE) logo. The logo consists of the letters "G" and "E" intertwined in a stylized, cursive font. The letters are enclosed within a circular border, and there are three small, curved lines extending outward from the circle at different points.

K10/778
4 of 4

GE Healthcare

Special 510(k) Premarket Notification Submission

  • · One system detects an interference condition.
  • The other system determines the attaching status of the device.

The Shuttle features an LED Display Board, which contains the battery runtime indicator and the battery health indicator.

Summary of Non-Clinical Tests: Determination of Substantial Equivalence:

The Giraffe Incubator and its applications with the Giraffe Shuttle, complies with voluntary standards as detailed in Section 9, 11 and 17 of this premarket submission. The following quality assurance measures were applied to the development of the system:

  • Risk Analysis .
  • Requirements Reviews ●
  • . Design Reviews
  • � Testing on unit level (Module verification)
  • . Integration testing (System verification)
  • . Performance testing (Verification)
  • . Safety testing (Verification)
  • . Usability testing (Validation)
  • . Biocompatibility testing

Clinical Tests:

The subject of this premarket submission, Giraffe Incubator used with Shuttle, did not require clinical studies to support substantial equivalence.

  • GE Healthcare considers the modified Giraffe Incubator, used with the Conclusion: Giraffe Shuttle accessory to be as safe, as effective, and performance is substantially equivalent to the legally marketed Giraffe Incubator.

4

Image /page/4/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three stripes representing the department's mission. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" is arranged in a circular fashion around the eagle.

DEPARTMENT OF HEALTH & HUMAN SERVICES

Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002

IJUL 2-1 2010

Mr. Agata Smieja Regulatory Affairs Director OHMEDA Medical 8880 Gorman Road Laurel, Maryland 20723

Re: K101778

Trade/Device Name: Giraffe Incubator Regulation Number: 21 CFR 880.5400 Regulation Name: Neonatal Incubator Regulatory Class: II Product Code: FMZ Dated: June 17, 2010 Received: June 25, 2010

Dear Mr. Smieja:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

5

Page 2- Mr. Smieja

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to

http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.

Sincerely yours,

Nh For

Anthony D. Watson, B.S., M.S., M.B.A. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

6

Image /page/6/Picture/0 description: The image shows the General Electric (GE) logo. The logo consists of the letters 'G' and 'E' intertwined within a circular border. The letters and the border are in black, while the background is white. The logo is simple and recognizable, representing the company's brand.

GE Healthcare Special 510(k) Premarket Notification Submission

510(k) Number (if known):

[INSERT 510(k) NUMBER IF KNOWN

K101778

Giraffe Incubator Device Name:

Indications for Use:

The Giraffe Incubator is an Infant Incubators provide heat in a controlled manner to neonates who are unable to thermo-regulate based on their own physiology. They achieve this by providing an enclosed temperature controlled environment to the infant. This device may incorporate a Servo Controlled Oxygen Delivery System. This is indicated to provide a stable oxygen concentration within the infant compartment at the value set by the operator (21-65%)

Prescription Use x (Part 21 CFR 801 Subpart D) AND/OR

Over-The-Counter Use_ (Part 21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Uli C. U 7/9/10
(Division Sign Off)

(Division Sign-Off) Division of Anesthesiology, General Hospital Infection Control, Dental Devices

510(k) Number: